3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other
1
Conditions
Multiple Myeloma
8
Pancreatic Neoplasms
7
Neoplasms
6
Neoplasms, Plasma Cell
4
Myelodysplastic Syndromes
4
Colorectal Neoplasms
3
Stomatitis
2
Skin Neoplasms
2
Prostatic Neoplasms
2
Ovarian Neoplasms
2
Myeloproliferative Disorders
2
Leukemia, Myeloid, Acute
2
Leukemia
2
Inflammation
2
Colonic Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Sarcoma
1
Recurrence
1
Primary Myelofibrosis
1
Myofibroma
1
Myelodysplastic-Myeloproliferative Diseases
1
Multiple Endocrine Neoplasia Type 1
1
Mucositis
1
Motor Activity
1
Lymphoma
1
Lung Neoplasms
1
Liver Neoplasms
1
Limb-girdle muscular dystrophy, type 2C
1
Interventions
Radiotherapy
6
Fibroblast Growth Factor 7
4
Injections
3
Drug Therapy
3
Cisplatin
3
Water
2
Propolis
2
Mouthwashes
2
Morphine
2
Methotrexate
2
Melphalan
2
Low-Level Light Therapy
2
Interleukin 1 Receptor Antagonist Protein
2
Gabapentin
2
Cryotherapy
2
peppermint oil
1
pegaspargase
1
oxycodone-acetaminophen
1
nelarabine
1
kang-lai-te
1
glucarpidase
1
fludarabine phosphate
1
fish oil triglycerides
1
cyclohexaneacetic acid
1
calcium phosphate
1
brilacidin
1
anise oil
1
amlexanox
1
aluminum hydroxide, magnesium hydroxide, drug combination
1
acetaminophen, hydrocodone drug combination
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Mucositis
×
Ascorbic Acid
×
Clear all
NCT01898091
2017-03-06
OM
Medical University of South Carolina
Phase 2
Completed
50 enrolled
9 charts